sq-11725 has been researched along with flunarizine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Artal-Roy, J; García-Gomara, MJ; Gracia-Naya, M; Latorre-Jiménez, AM; Mauri-Llerda, JA; Ríos-Gómez, C; Sánchez-Valiente, S; Santos-Lasaosa, S | 1 |
| Artal-Roy, J; Garcia-Gomara, MJ; Gracia-Naya, M; Huerta-Villanueva, M; Latorre-Jimenez, AM; Mauri-Llerda, JA; Rios, C; Sanchez-Valiente, S; Santos-Lasaosa, S | 1 |
3 other study(ies) available for sq-11725 and flunarizine
| Article | Year |
|---|---|
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
[Predisposing factors affecting drop-out rates in preventive treatment in a series of patients with migraine].
Topics: Adrenergic beta-Antagonists; Adult; Anticonvulsants; Female; Flunarizine; Fructose; Humans; Male; Middle Aged; Migraine Disorders; Nadolol; Neuroprotective Agents; Patient Dropouts; Patient Satisfaction; Prospective Studies; Risk Factors; Topiramate; Treatment Outcome; Young Adult | 2011 |
[A study to compare independent groups of patients with episodic migraine who were treated preventively with flunarizine or nadolol].
Topics: Adrenergic beta-Antagonists; Adult; Calcium Channel Blockers; Female; Flunarizine; Humans; Male; Migraine Disorders; Nadolol | 2012 |